Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
364.13B | 353.90B | 356.43B | 340.45B | 306.07B | 272.64B | Gross Profit |
167.24B | 157.97B | 169.13B | 165.24B | 143.65B | 137.59B | EBIT |
21.44B | 8.31B | 20.00B | 8.17B | 17.60B | 13.18B | EBITDA |
62.22B | 30.15B | 58.43B | 56.89B | 62.29B | 38.26B | Net Income Common Stockholders |
5.90B | -12.89B | -3.22B | -8.46B | 16.91B | 5.28B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
36.52B | 51.82B | 63.25B | 97.63B | 63.96B | 50.19B | Total Assets |
546.39B | 564.33B | 561.57B | 591.32B | 569.02B | 529.76B | Total Debt |
264.28B | 285.05B | 292.62B | 307.94B | 321.55B | 335.02B | Net Debt |
227.75B | 238.00B | 231.68B | 212.70B | 260.79B | 289.65B | Total Liabilities |
401.92B | 425.16B | 422.74B | 455.26B | 461.46B | 459.46B | Stockholders Equity |
144.89B | 139.51B | 138.01B | 135.37B | 107.02B | 70.28B |
Cash Flow | Free Cash Flow | ||||
28.16B | 26.67B | 9.86B | 39.32B | 35.70B | 24.13B | Operating Cash Flow |
40.44B | 41.30B | 21.38B | 51.05B | 47.85B | 36.87B | Investing Cash Flow |
-12.83B | -21.07B | -17.52B | -12.52B | -16.31B | -135.47B | Financing Cash Flow |
-36.06B | -39.14B | -40.83B | -7.01B | -20.39B | 95.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $4.09T | 32.79 | 9.39% | 0.96% | 14.23% | 26.82% | |
75 Outperform | $1.65T | 28.48 | 13.12% | 1.15% | 14.50% | 29.02% | |
74 Outperform | ¥9.20T | 37.46 | 10.53% | 0.40% | 9.25% | 26.69% | |
69 Neutral | $2.27T | 27.74 | 12.71% | 1.04% | 7.60% | -66.30% | |
67 Neutral | €121.10B | 20.49 | 4.31% | 4.50% | 4.63% | ― | |
65 Neutral | ¥1.10T | 18.81 | 6.83% | 3.72% | 5.63% | 30.61% | |
52 Neutral | $5.21B | 3.49 | -43.30% | 2.83% | 14.70% | -0.24% |